Latest Insider Transactions at Frequency Therapeutics, Inc. (FREQ)
This section provides a real-time view of insider transactions for Frequency Therapeutics, Inc. (FREQ). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Frequency Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Frequency Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 10
2023
|
David L. Lucchino |
BUY
Exercise of conversion of derivative security
|
Direct |
9,091
+1.97%
|
-
|
|
Jul 10
2023
|
David L. Lucchino |
SELL
Open market or private sale
|
Direct |
2,591
-0.58%
|
$0
$0.38 P/Share
|
|
Jul 10
2023
|
Richard J. Mitrano VP Finance & Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
758
+2.22%
|
-
|
|
Jul 10
2023
|
Richard J. Mitrano VP Finance & Operations |
SELL
Open market or private sale
|
Direct |
220
-0.67%
|
$0
$0.37 P/Share
|
|
Jul 07
2023
|
Christopher R. Loose Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,546
+6.33%
|
-
|
|
Jul 07
2023
|
Christopher R. Loose Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,306
-2.04%
|
$0
$0.36 P/Share
|
|
Jul 07
2023
|
David L. Lucchino |
BUY
Exercise of conversion of derivative security
|
Direct |
9,091
+2.0%
|
-
|
|
Jul 07
2023
|
David L. Lucchino |
SELL
Open market or private sale
|
Direct |
2,634
-0.6%
|
$0
$0.35 P/Share
|
|
Jul 07
2023
|
Richard J. Mitrano VP Finance & Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
758
+2.26%
|
-
|
|
Jul 07
2023
|
Richard J. Mitrano VP Finance & Operations |
SELL
Open market or private sale
|
Direct |
220
-0.68%
|
$0
$0.36 P/Share
|
|
Jul 06
2023
|
Richard J. Mitrano VP Finance & Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
758
+2.29%
|
-
|
|
Jul 06
2023
|
Richard J. Mitrano VP Finance & Operations |
SELL
Open market or private sale
|
Direct |
224
-0.71%
|
$0
$0.35 P/Share
|
|
Jul 06
2023
|
Christopher R. Loose Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,384
-2.34%
|
$0
$0.34 P/Share
|
|
Jul 06
2023
|
Christopher R. Loose Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,546
+7.14%
|
-
|
|
Jul 06
2023
|
David L. Lucchino |
BUY
Exercise of conversion of derivative security
|
Direct |
9,091
+2.03%
|
-
|
|
Jul 06
2023
|
David L. Lucchino |
SELL
Open market or private sale
|
Direct |
2,773
-0.64%
|
$0
$0.34 P/Share
|
|
Jul 05
2023
|
Richard J. Mitrano VP Finance & Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
758
+2.33%
|
-
|
|
Jul 05
2023
|
Christopher R. Loose Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,546
+7.69%
|
-
|
|
Jul 05
2023
|
David L. Lucchino |
BUY
Exercise of conversion of derivative security
|
Direct |
9,091
+2.06%
|
-
|
|
Jul 06
2022
|
Richard J. Mitrano VP Finance & Operations |
SELL
Open market or private sale
|
Direct |
2,184
-6.58%
|
$2,184
$1.54 P/Share
|
|
Jul 06
2022
|
Christopher R. Loose Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
4,415
-8.11%
|
$4,415
$1.53 P/Share
|
|
Jul 06
2022
|
Quentin Mc Cubbin Chief Manufacturing Officer |
SELL
Open market or private sale
|
Direct |
6,569
-14.63%
|
$6,569
$1.52 P/Share
|
|
Jul 06
2022
|
Carl Le Bel Chief Development Officer |
SELL
Open market or private sale
|
Direct |
4,421
-14.37%
|
$4,421
$1.52 P/Share
|
|
Jul 06
2022
|
Wendy S Arnold Chief People Officer |
SELL
Open market or private sale
|
Direct |
5,638
-21.02%
|
$5,638
$1.52 P/Share
|
|
Jul 05
2022
|
Richard J. Mitrano VP Finance & Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+18.44%
|
-
|
|
Jul 05
2022
|
Christopher R. Loose Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+21.59%
|
-
|
|
Jul 05
2022
|
Quentin Mc Cubbin Chief Manufacturing Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17,500
+28.04%
|
-
|
|
Jul 05
2022
|
Carl Le Bel Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+32.78%
|
-
|
|
Jul 05
2022
|
Wendy S Arnold Chief People Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+35.86%
|
-
|
|
Feb 22
2022
|
Wendy S Arnold Chief People Officer |
SELL
Open market or private sale
|
Direct |
1,326
-10.08%
|
$3,978
$3.53 P/Share
|
|
Feb 22
2022
|
Quentin Mc Cubbin Chief Manufacturing Officer |
SELL
Open market or private sale
|
Direct |
1,584
-6.5%
|
$4,752
$3.53 P/Share
|
|
Feb 22
2022
|
Carl Le Bel Chief Development Officer |
SELL
Open market or private sale
|
Direct |
1,069
-8.77%
|
$3,207
$3.53 P/Share
|
|
Feb 22
2022
|
Peter P. Pfreundschuh Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,542
-14.73%
|
$4,626
$3.53 P/Share
|
|
Feb 22
2022
|
Christopher R. Loose Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,069
-2.98%
|
$3,207
$3.53 P/Share
|
|
Feb 18
2022
|
Wendy S Arnold Chief People Officer |
SELL
Open market or private sale
|
Direct |
1,209
-8.42%
|
$3,627
$3.87 P/Share
|
|
Feb 18
2022
|
Quentin Mc Cubbin Chief Manufacturing Officer |
SELL
Open market or private sale
|
Direct |
1,411
-5.48%
|
$4,233
$3.87 P/Share
|
|
Feb 18
2022
|
Carl Le Bel Chief Development Officer |
SELL
Open market or private sale
|
Direct |
974
-7.4%
|
$2,922
$3.87 P/Share
|
|
Feb 18
2022
|
Peter P. Pfreundschuh Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,404
-11.83%
|
$4,212
$3.88 P/Share
|
|
Feb 18
2022
|
Christopher R. Loose Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
974
-2.64%
|
$2,922
$3.87 P/Share
|
|
Feb 17
2022
|
Wendy S Arnold Chief People Officer |
SELL
Open market or private sale
|
Direct |
1,118
-7.22%
|
$4,472
$4.19 P/Share
|
|
Feb 17
2022
|
Quentin Mc Cubbin Chief Manufacturing Officer |
SELL
Open market or private sale
|
Direct |
1,303
-4.81%
|
$5,212
$4.2 P/Share
|
|
Feb 17
2022
|
Carl Le Bel Chief Development Officer |
SELL
Open market or private sale
|
Direct |
901
-6.4%
|
$3,604
$4.19 P/Share
|
|
Feb 17
2022
|
Christopher R. Loose Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
900
-2.38%
|
$3,600
$4.19 P/Share
|
|
Feb 17
2022
|
Peter P. Pfreundschuh Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,296
-9.84%
|
$5,184
$4.2 P/Share
|
|
Feb 16
2022
|
Wendy S Arnold Chief People Officer |
SELL
Open market or private sale
|
Direct |
1,057
-6.39%
|
$4,228
$4.43 P/Share
|
|
Feb 16
2022
|
Quentin Mc Cubbin Chief Manufacturing Officer |
SELL
Open market or private sale
|
Direct |
1,233
-4.36%
|
$4,932
$4.43 P/Share
|
|
Feb 16
2022
|
Carl Le Bel Chief Development Officer |
SELL
Open market or private sale
|
Direct |
831
-5.58%
|
$3,324
$4.43 P/Share
|
|
Feb 16
2022
|
Christopher R. Loose Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
851
-2.2%
|
$3,404
$4.43 P/Share
|
|
Feb 16
2022
|
Peter P. Pfreundschuh Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,229
-8.54%
|
$4,916
$4.43 P/Share
|
|
Feb 15
2022
|
Wendy S Arnold Chief People Officer |
SELL
Open market or private sale
|
Direct |
1,168
-6.6%
|
$4,672
$4.33 P/Share
|